Cargando…
Gut Microbiome Metabolism Drives the Resolution of Patients With Coronavirus Disease 2019
Autores principales: | Zhang, Yu-Hang, Wang, Wen-Yu, Cui, Yi-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697479/ https://www.ncbi.nlm.nih.gov/pubmed/34954225 http://dx.doi.org/10.1053/j.gastro.2021.12.261 |
Ejemplares similares
-
Intestinal Microbiome Modulation During Coronavirus Disease 2019: Another Chance to Manage the Disease?
por: Tursi, Antonio, et al.
Publicado: (2022) -
Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021) -
Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019
por: Huang, Lan, et al.
Publicado: (2020) -
Famotidine and Mortality in Coronavirus Disease 2019
por: Sethia, Rahul, et al.
Publicado: (2021) -
Asthma and prognosis of coronavirus disease 2019
por: Özdemir, Öner
Publicado: (2022)